Almhanna, Khaldoun
Wright, David
Mercade, Teresa Macarulla
Van Laethem, Jean-Luc
Gracian, Antonio Cubillo
Guillen-Ponce, Carmen
Faris, Jason
Lopez, Carolina Muriel
Hubner, Richard A.
Bendell, Johanna
Bols, Alain
Feliu, Jaime
Starling, Naureen
Enzinger, Peter
Mahalingham, Devalingham
Messersmith, Wells
Yang, Huyuan
Fasanmade, Adedigbo
Danaee, Hadi
Kalebic, Thea
Funding for this research was provided by:
Millennium Pharmaceuticals Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited
Article History
Received: 2 May 2017
Accepted: 10 May 2017
First Online: 19 May 2017
Compliance with ethical standards
:
: Khaldoun Almhanna: Lilly advisor/board member, Genentech Speaker’s bureau. Jason Faris: Current employee of Novartis; consultant for Merrimack Pharmaceuticals and N-of-One Therapeutics; research for Exelixis, Millennium, Agios, and Roche/Genentech. Richard A. Hubner: Advisory Board payments from Celgene and BTG. Jaime Feliu: Advisor/honoraria for Sanofi, Amgen, Bayer, Lilly. Peter Enzinger; Speaker’s bureau for Merck esophageal cancer. Devalingham Mahalingham: Advisory board for Bayer, Baxalta, and Genspera; Speaker bureau for Genentech, Amgen, and Bayer. Wells Messersmith: Research support from Millennium. Huyuan Yang, Adedigbo Fasanmade, Hadi Danaee, Thea Kalebic: Employees of Millennium. David Wright, Teresa Macarulla Mercade, Jean-Luc Van Laethem, Antonio Cubillo Gracian, Carmen Guillen-Ponce, Carolina Muriel Lopez, Johanna Bendell, Alain Bols, Naureen Starling: nothing to disclose.
: This study was funded by Millennium Pharmaceuticals Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited.
: The institutional review boards and independent ethics committees reviewed all appropriate study documentation to safeguard the rights, safety, and well-being of the patients. Written informed consent was obtained from each patient prior to initiating study participation, in compliance with International Conference on Harmonisation-Good Clinical Practices guidelines, the principles set out in the Declaration of Helsinki, and all applicable regulatory requirements.
: The study was conducted in compliance with the protocol, Good Clinical Practices, applicable regulatory requirements, and International Conference on Harmonisation guidelines.